- ATAI Life Sciences NV Announces Strategic Investment in Beckley Psytech Ltd Call TranscriptJan 04, 2024
- Q3 2022 ATAI Life Sciences NV Earnings Presentation TranscriptNov 10, 2022
- ATAI Life Sciences NV R&D Investor Day TranscriptOct 25, 2022
- ATAI Life Sciences NV at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 ATAI Life Sciences NV Earnings Presentation TranscriptAug 15, 2022
- ATAI Life Sciences NV at Citi Biopharma Co-Panel Day (Virtual) TranscriptMay 18, 2022
- Q1 2022 ATAI Life Sciences NV Earnings Call TranscriptMay 16, 2022€3.46 (-1.99%)Earnings
- Q4 2021 ATAI Life Sciences NV Earnings Call TranscriptMar 30, 2022€4.82 (+7.59%)Earnings
- ATAI Life Sciences NV at Citi Winter Biotech Virtual Bus Tour TranscriptMar 22, 2022
- Atai Life Sciences N.V. - Special Call TranscriptJan 18, 2022
- Q3 2021 ATAI Life Sciences NV Earnings Call TranscriptNov 15, 2021€11.36 (-11.66%)Earnings
- ATAI Life Sciences NV at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
ATAI Life Sciences NV at Citi Biopharma Co-Panel Day (Virtual) Transcript
All right. Hi, everybody. Thank you for joining today's virtual company panel day. If you don't know me, my name is Neena Bitritto-Garg. I'm one of the biotech analysts here at Citi.
And for our next panel, we'll be discussing mood disorders and mental health. And I'm really pleased to be joined by executives from 4 companies working in the space, including at Atai Life Sciences, Bionomics, COMPASS Pathways and Praxis Precision Medicines.
And before we do get into Q&A, I just wanted to flag that if you do have any questions, you can feel free to send me an e-mail directly. My email address is listed on the webcast. You can find me on Bloomberg and ping me that way, whatever works for you.
So now I just wanted to turn it over to our panelists. Maybe if we go alphabetically by company names. So maybe Srini, if you want to start, introduce yourself and give some opening remarks on Atai and then we can go around, yes, alphabetically by company name.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)